Free Trial
NASDAQ:QNTM

Quantum Biopharma (QNTM) Stock Price, News & Analysis

Quantum Biopharma logo
$16.94 -0.31 (-1.80%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Quantum Biopharma Stock (NASDAQ:QNTM)

Key Stats

Today's Range
$16.57
$17.50
50-Day Range
$16.35
$35.00
52-Week Range
$2.70
$38.25
Volume
34,112 shs
Average Volume
1.17 million shs
Market Capitalization
$65.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive QNTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QNTM Stock News Headlines

Quantum Group announces corporate updates
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
See More Headlines

QNTM Stock Analysis - Frequently Asked Questions

Quantum Biopharma's stock was trading at $3.68 at the start of the year. Since then, QNTM stock has increased by 364.4% and is now trading at $17.09.

Quantum Biopharma Ltd. (NASDAQ:QNTM) issued its quarterly earnings results on Wednesday, August, 6th. The company reported ($3.23) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $3.06.

Top institutional shareholders of Quantum Biopharma include AdvisorShares Investments LLC (1.27%) and Steward Partners Investment Advisory LLC (0.11%).

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Last Earnings
8/06/2025
Today
8/29/2025
Next Earnings (Estimated)
11/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QNTM
Previous Symbol
NASDAQ:QNTM
CIK
1771885
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-270.22%
Return on Assets
-131.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.78
Quick Ratio
0.77

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.53 per share
Price / Book
32.42

Miscellaneous

Outstanding Shares
3,880,000
Free Float
3,548,000
Market Cap
$66.68 million
Optionable
N/A
Beta
0.71
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:QNTM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners